Clinical Trials Browser

Interventional × Has announcements × Ramucirumab × Clear all

NCT02411448 2026-01-16

RELAY

Phase 3 Active not recruiting

545 enrolled 24 charts 2 FDA

Carcinoma, Non-Small-Cell Lung

NCT02435433 2023-01-20

REACH-2

Phase 3 Completed

399 enrolled 22 charts 1 FDA

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms